Skip to main content

French Agency Awards Transgene $33M for Pharmacogenomics Program

NEW YORK (GenomeWeb News) - Transgene said today that the French Agency for Industrial Innovation has awarded it €25 million ($32.7 million) to participate in a pharmacogenomics project called ADNA (Advanced Diagnostics and New therapeutic Approaches).
 
ADNA includes four partners -- Transgene, bioMerieux, Genethon, and GenoSafe -- and aims to improve personalized medicine in the fields of cancer, infectious diseases, and rare genetic diseases.
 
According to a statement from Transgene, the “core” of the program will be the development and validation of biomarkers to help guide the prescription of new treatments to those patients most likely to benefit from them.
 
The funding is subject to European Commission approval, which is expected in the second quarter of 2007, Transgene said.
 
The funding includes grants of €17.8 million and loans of €7.2 million refundable only in the case of success.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.